> Anti-trans campaigners misunderstand what's meant by "low quality evidence". It just means we don't yet have double blind randomised control trials of certain treatments.
No it doesn’t. The problems run far deeper. Read the interim report, pages 18-19[1]:
> 1.24. A lack of a conceptual agreement about the meaning of gender dysphoria hampers research, as well as NHS clinical service provision.
> 1.25. There has not been routine and consistent data collection within GIDS, which means it is not possible to accurately track the outcomes and pathways
that children and young people take through the service.
> 1.26. Internationally as well as nationally, longer-term follow-up data on children and young people who have been seen by gender identity services is limited, including for those who have received physical interventions; who were transferred to adult services and/or accessed private services; or who desisted, experienced regret or detransitioned.
> 1.27. There has been research on the short-term mental health outcomes and physical side effects of puberty blockers for this cohort, but very limited research on the sexual, cognitive or broader developmental outcomes.
This is not about a lack of rigorously designed experiments. This is about very basic gaps in definitions, data collection, and followup. This is not a case of “we did some research and it’s basically fine but the science police won’t acknowledge the result because we didn’t fill the form out correctly”. We fundamentally do not have the evidence.
Additionally, the new UK regional centers are not an expansion of gender-affirming care, they are an expansion of care, period. The presumption of gender affirmation was explicitly criticized, and in the forthcoming service model there is a requirement to deal with the whole clinical presentation.
None of this has any bearing on being “pro-trans” or “anti-trans”. It is about uplifting treatment for gender dysphoria to the same standards of evidence-based medicine that we expect for any other clinical issue.
Yes it does. You not knowing what GRADE is or how it works but insisting that you are well informed is a great example of the problem with these discussions. You dump a load of ill-informed mangled sources into a thread, and now I have to spend a few hours explaining how you're misrepresenting the sources.
> Additionally, the new UK regional centers are not an expansion of gender-affirming care, they are an expansion of care, period. The presumption of gender affirmation was explicitly criticized, and in the forthcoming service model there is a requirement to deal with the whole clinical presentation.
I've read the service specification for the new centres. (Have you?) It's an expansion of gender affirming care, and there's no way to spin it otherwise. There will be more clinics treating more children in a more timely way. More children will have access to puberty blockers. What's that if it's not an expansion of service?
> None of this has any bearing on being “pro-trans” or “anti-trans”.
All the information you've posted to this thread so far is sourced to anti-trans organisations. At least be honest about it. You are anti-trans, you post anti-trans disinformation from anti-trans links.
I mean, you're making the same three claims as if they're magic gotchas but you don't understand what you're saying.
1) Care at tavistock is bad
Yes, everyone agrees, that's why people are pleased that Cass recommends the NHS continues its long established plan to remove care from Tavi.
2) There's no evidence
There's plenty of evidence. It doesn't come from tavi, but that's because they provide so little care it's not possible to use their patients as experimental subjects. We have lots of evidence from other countries and other patient cohorts
3) Cass says...
Mostly you're misunderstanding what Cass says, or you're relying on the single source that agrees with you and ignoring international scientific and medical opinion.
4) The new centres are providing less gender affirming care than tavi
The vast majority of children attending tavi got no care at all because they were on a waiting list and then aged out of children's services. But even if they got treatment at tavi the vast majority got no meds at all but psycho-social advice. The new centres will be doing this too, but with more children and with smaller waiting lists and the shared care agreements with GPs will be clearer.
No it doesn’t. The problems run far deeper. Read the interim report, pages 18-19[1]:
> 1.24. A lack of a conceptual agreement about the meaning of gender dysphoria hampers research, as well as NHS clinical service provision.
> 1.25. There has not been routine and consistent data collection within GIDS, which means it is not possible to accurately track the outcomes and pathways that children and young people take through the service.
> 1.26. Internationally as well as nationally, longer-term follow-up data on children and young people who have been seen by gender identity services is limited, including for those who have received physical interventions; who were transferred to adult services and/or accessed private services; or who desisted, experienced regret or detransitioned.
> 1.27. There has been research on the short-term mental health outcomes and physical side effects of puberty blockers for this cohort, but very limited research on the sexual, cognitive or broader developmental outcomes.
This is not about a lack of rigorously designed experiments. This is about very basic gaps in definitions, data collection, and followup. This is not a case of “we did some research and it’s basically fine but the science police won’t acknowledge the result because we didn’t fill the form out correctly”. We fundamentally do not have the evidence.
Additionally, the new UK regional centers are not an expansion of gender-affirming care, they are an expansion of care, period. The presumption of gender affirmation was explicitly criticized, and in the forthcoming service model there is a requirement to deal with the whole clinical presentation.
None of this has any bearing on being “pro-trans” or “anti-trans”. It is about uplifting treatment for gender dysphoria to the same standards of evidence-based medicine that we expect for any other clinical issue.
I agree, sources are frequently misrepresented.
[1] https://cass.independent-review.uk/wp-content/uploads/2022/0...